| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 447 | 2020 |
| Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe J Fernández, V Prado, J Trebicka, A Amoros, T Gustot, R Wiest, ... Journal of hepatology 70 (3), 398-411, 2019 | 316 | 2019 |
| PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 74 (5), 1097-1108, 2021 | 253 | 2021 |
| Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective, multicentre, nationwide cohort KB Gecse, BD Lovász, K Farkas, J Banai, L Bene, B Gasztonyi, ... Journal of Crohn's and Colitis 10 (2), 133-140, 2016 | 226 | 2016 |
| Immune dysfunction in cirrhosis N Sipeki, P Antal-Szalmas, PL Lakatos, M Papp World journal of gastroenterology: WJG 20 (10), 2564, 2014 | 203 | 2014 |
| Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in … LS Kiss, T Szamosi, T Molnar, P Miheller, L Lakatos, A Vincze, K Palatka, ... Alimentary pharmacology & therapeutics 34 (8), 911-922, 2011 | 198 | 2011 |
| New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a … M Papp, I Altorjay, N Dotan, K Palatka, I Foldi, J Tumpek, S Sipka, ... Official journal of the American College of Gastroenterology| ACG 103 (3 …, 2008 | 181 | 2008 |
| Utility of serological markers in inflammatory bowel diseases: gadget or magic? M Papp, GL Norman, I Altorjay, PL Lakatos World journal of gastroenterology: WJG 13 (14), 2028, 2007 | 172 | 2007 |
| Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections M Papp, Z Vitalis, I Altorjay, I Tornai, M Udvardy, J Harsfalvi, A Vida, ... Liver International 32 (4), 603-611, 2012 | 153 | 2012 |
| Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease KE Müller, PL Lakatos, A Arató, JB Kovács, Á Várkonyi, D Szucs, ... Journal of pediatric gastroenterology and nutrition 57 (5), 576-582, 2013 | 140 | 2013 |
| Hypertriglyceridemia-induced acute pancreatitis: A prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases D Mosztbacher, L Hanák, N Farkas, A Szentesi, A Mikó, J Bajor, P Sarlós, ... Pancreatology 20 (4), 608-616, 2020 | 135 | 2020 |
| Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets B Mesko, S Poliskal, A Szegedi, Z Szekanecz, K Palatka, M Papp, L Nagy BMC medical genomics 3, 1-13, 2010 | 133 | 2010 |
| Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations A Párniczky, T Lantos, EM Tóth, Z Szakács, S Gódi, R Hágendorn, D Illés, ... Pancreatology 19 (4), 488-499, 2019 | 127 | 2019 |
| EASL Clinical Practice Guidelines on acute-on-chronic liver failure R Moreau, M Tonon, A Krag, P Angeli, M Berenguer, A Berzigotti, ... Journal of hepatology 79 (2), 461-491, 2023 | 122 | 2023 |
| High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification? L Sandor Kiss, M Papp, B Dorottya Lovasz, Z Vegh, P Anna Golovics, ... Inflammatory bowel diseases 18 (9), 1647-1654, 2012 | 119 | 2012 |
| Acute-on-chronic liver failure: A distinct clinical syndrome R Moreau, B Gao, M Papp, R Bañares, PS Kamath Journal of hepatology 75, S27-S35, 2021 | 117 | 2021 |
| Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease PL Lakatos, LS Kiss, K Palatka, I Altorjay, P Antal-Szalmas, E Palyu, ... Inflammatory bowel diseases 17 (3), 767-777, 2011 | 103 | 2011 |
| Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy T Molnár, PL Lakatos, K Farkas, F Nagy, Z Szepes, P Miheller, G Horváth, ... Alimentary pharmacology & therapeutics 37 (2), 225-233, 2013 | 99 | 2013 |
| Mucosal expression of claudins 2, 3 and 4 in proximal and distal part of duodenum in children with coeliac disease D Nagy Szakál, H Győrffy, A Arató, Á Cseh, K Molnár, M Papp, A Dezsőfi, ... Virchows Archiv 456, 245-250, 2010 | 99 | 2010 |
| Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype … M Papp, I Altorjay, GL Norman, Z Shums, K Palatka, Z Vitalis, I Foldi, ... Inflammatory bowel diseases 13 (8), 984-992, 2007 | 97 | 2007 |
Nóra Sipeki MD, PhDUniversity of Debrecen; Department of Internal Medicine, Division of GastroenterologyBestätigte E-Mail-Adresse bei med.unideb.hu